High expression of Myc has been described as a prognostic biomarker in a variety of human STS (e.g. leiomyosarcomas, osteosarcomas and liposarcomas) and a high frequency of MYC gene amplification is associated with radiation-induced sarcomas [60], [61], [62], [63]. Here, MYC is linked to leiomyosarcoma.